Payers

Dementia prevention has a cardiometabolic blind spot

Childhood obesity is the next cardiometabolic crisis already unfolding

Europe Opens Another Lung Cancer Door to China-Origin Immunotherapy

In Australia, Cancer Medicine Delays Cost More Than Time

Cardiac rehab saves lives. Health systems still treat it like optional aftercare

BMI is not enough. Cardiometabolic risk is hiding in where fat lives

Resistant hypertension may need a diagnostic revolution, not just another drug

When diabetes tech fails, personalised care fails with it

AI genomics market set to hit $9.3B by 2030, but regulation and equity gaps remain unresolved
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
